Towards the structure of the human immunodeficiency virus: Divide and conquer?

Current Opinion in Structural Biology

Volumn 9, Issue 2, 1999, Pages 231-243

  Wilk, Thomas ^a   Fuller, Stephen D ^a  

^a EUROPEAN MOLECULAR BIOLOGY LABORATORY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CAPSID PROTEIN; GAG PROTEIN; NUCLEOCAPSID PROTEIN; STRUCTURAL PROTEIN; VIRUS PROTEIN; VIRUS RNA;

HUMAN IMMUNODEFICIENCY VIRUS; PRIORITY JOURNAL; PROTEIN CONFORMATION; REVIEW; VIRUS ASSEMBLY; VIRUS MORPHOLOGY; VIRUS REPLICATION;

HUMAN IMMUNODEFICIENCY VIRUS; MIRIDAE;

EID: 0033117918     PISSN: 0959440X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0959-440X(99)80033-5     Document Type: Article

References (97)

1. Frankel AD, Young JA: HIV-1 : Fifteen proteins and an RNA. Annu Rev Biochem 1998, 67:1-25. A recent review summarizing structural and functional data for the 15 individual proteins and the viral RNA of HIV.
2. Caffrey M, Cai M, Kaufman J, Stahl SJ, Wingfield PT, Covell DG, Gronenborn AM, Clore GM: Three dimensional solution structure of the 44 kDa ectodomain of SIV gp41. EM BO J 1998, 17:4572-4584. The most recent and complete structure of a lentivirus transmembrane protein (TM). The authors determined the solution structure of the portion of the SIV gp41 trimer located between the transmembrane region and the fusion sequence. They present a comparison with the structures of shorter regions of TM and a model for TM function in fusion that posits no dramatic conformational change.
3. Kwong PD, Wyatt R, Robinson J, Sweet RW, Sodroski J, Hendrickson WA: Structure of an HIV gp120 envelope glycoprotein in complex with the CD4 receptor and a neutralizing human antibody. Nature 1998, 393:648-659. The structure of the core of gp120 in complex with a portion of CD4 and an antibody for which binding is accentuated by CD4 binding. The authors give evidence for conformational changes in gp120 and the possible role of these changes in the avoidance of immune surveillance and the regulation of fusion.
4. Vogt VM: Retroviral virions and genomes. In Retroviruses. Edited by Coffin JM, Hughes SH, Varmus HE. Cold Spring Harbor, New York: Cold Spring Harbor Laboratory Press; 1997:27-70.
5. Leis J, Baltimore D, Bishop JM, Coffin J, Fleissner E, Goff SP, Oroszlan S, Robinson H, Skalka AM, Temin HM et al.: Standardized and simplified nomenclature for proteins common to all retroviruses. J Virol 1988, 62:1808-1809.
6. Coffin JM, Hughes SH, Varmus He (Editors): Retroviruses. Cold Spring Harbor, New York: Cold Spring Harbor Laboratory Press; 1997. The new 'bible' of modern retrovirology. This excellent textbook gives a detailed description of all aspects of the retroviral life cycle.
7. Cullen BR: Human immunodeficiency virus as a prototypic complex retrovirus. J Virol 1991, 65:1053-1056.
8. Cullen BR: Mechanism of action of regulatory proteins encoded by complex retroviruses. Microbiol Rev 1992, 56:375-394.
9. Swanstrom R, Wills JW: Synthesis, assembly and processing of viral proteins. In Retroviruses. Edited by Coffin JM, Hughes SH, Varmus HE. Cold Spring Harbor, New York: Cold Spring Harbor Laboratory Press; 1997:263-334.
10. Gelderblom HR: Assembly and morphology of HIV: Potential effect of structure on viral function. AIDS 1991, 5:617-638.
11. Baker TS, Olson NH, Fuller SD: Adding the third dimension to virus life cycles: Three-dimensional reconstruction of icosahedral viruses from cryo-electron micrographs. Microbiol Mol Biol Rev 1999, in press.
12. Fuller SD, Butcher SJ, Cheng RH, Baker TS: Three-dimensional reconstruction of icosahedral particles: The uncommon line. J Struct Biol 1996, 116:48-65.
13. Mancini EJ, de Haas F, Fuller SD: High resolution icosahedral reconstruction: Fulfilling the promise of cryo-electron microscopy. Structure 1997, 5:741-750.
14. Fuller SD, Wilk T, Gowen BE, Kräusslich H-G, Vogt VM: Cryo electron microscopy reveals ordered domains within the immature HIV-1 particle. Curr Biol 1997, 7:729-738. This paper describes the first cryoelectron microscopy study of the structural organization of virus-like particles and HIV-1 particles. The authors demon-strate the lack of icosahedral symmetry and the presence of locally ordered domains in the virions. Radial density analysis of HIV particles reveals the presence of separately folded domains in the Gag precursor protein.
15. Roberts NA, Martin JA, Kinchington D, Broadhurst AV, Craig JC, Duncan IS, Galpin SA, Handa BK, Kay J, Kröhn A et al.: Rational design of peptide-based HIV protease inhibitors. Science 1990, 248:358-361.
16. Gheysen D, Jacobs E, De Foresta F, Thiriart C, Francotte M, Thinnes D, De Wilde M: Assembly and release of HIV-1 precursor Pr55gag virus-like particles from recombinant baculovirus-infected insect cells. Cell 1989, 59:103-112.
17. Caspar DLD, Klug A: Physical principles in the construction of regular viruses. Cold Spring Harb Symp Quant Biol 1962, 27:1 -24.
18. Fuller SD, Berriman JA, Butcher SJ, Gowen BE: Low pH induces the swivelling of the glycoprotein heterodimers in the Semliki forest virus spike complex. Cell 1995, 81:715-725.
19. Fuller SD: The T=4 envelope of sindbis virus is organized by complementary interactions with a T=3 icosahedral capsid. Cell 1987, 48:923-934.
20. Butcher SJ, Bamford DH, Fuller SD: DNA packaging orders the membrane of bacteriophage PRD1. EMBO J 1995, 14:6078-6086.
21. Stewart P, Fuller SD, Burnett RM: Difference imaging of adenovirus: Bridging the resolution map between X-ray crystallography and electron microscopy. Eur Mol Biol Org J 1993, 12:2589-2599.
22. Nermut MV, Frank H, Schäfer W: Properties of mouse leukemia viruses: III. Electron microscopic appearance as revealed after conventional preparation techniques as well as freeze drying and freeze etching. Virology 1972, 49:345-358.
23. Nermut MV: Size, shape and surface structure of mouse mammary tumour virus (MTV). Brief report. Arch Gesamte Virusforsch 1973, 41:284-289.
24. Gelderblom HR, Hausmann EHS, Örzel M, Pauli G, Koch MA: Fine structure of human immunodeficiency virus (HIV) and immunolocalization of structural proteins. Virology 1987, 156:171 -176.
25. Nermut MV, Grief C, Hashmi S, Hockley DJ: Further evidence of icosahedral symmetry in human and simian immunodeficiency virus. AIDS Res Hum Retroviruses 1993, 9:929-938.
26. Nermut MV, Hockley DJ, Jowett JB, Jones IM, Garreau M, Thomas D: Fullerene-like organization of HIV gag-protein shell in virus-like particles produced by recombinant baculovirus. Virology 1994, 198:288-296.
27. Nermut MV, Hockley DJ: Comparative morphology and structural classification of retroviruses. In Morphogenesis and Maturation of Retroviruses. Edited by Kräusslich H-G. Heidelberg: Springer Verlag; 1996:1-24.
28. Bugelski PJ, Maleeff BE, Klinkner AM, Ventre J, Hart TM: Ultrastructural evidence of an interaction between Env and Gag proteins during assembly of HIV type 1. AIDS Res Hum Retroviruses 1995, 11:55-64.
29. Marx PA, Munn RJ, Joy KI: Computer emulation of thin section electron microscopy predicts and envelope associated icosadeltahedral capsid for human immunodeficiency virus. Lab Invest 1988, 58:112-118.
30. Höglund S, Öfverstedt, Nilson A, Lundqvist P, Gelderbloom HR, Ozel MUS: Spatial visualization of the maturing HIV-1 core and its linkage to the envelope. AIDS Res Hum Retroviruses 1992, 8:1-7.
31. Nilsson A, Lunqvist P, Love A, Torfason E, Gelderblom HR, Hoglund S: Spatial visualization of progressive states of maturing lentivirus. Vet Microbiol 1992, 33:333-340.
32. Yeager M, Wilson-Kubalek EM, Weiner SG, Brown PO, Rein A: Supramolecular design of native and immature murine leukemia virus revealed by electron cryo-microscopy. Proc Natl Acad Sci USA 1998, 95:7299-7304. The authors used cryoelectron microscopy to study the structural organization of the Moloney murine leukemia virus. The study demonstrated a lack of icosahedral symmetry. Radial density analysis of virus particles demonstrated the presence of separately folded domains in the Gag precursor, similar to that reported for HIV.
33. Barklis EJM, Wilkens S, Schabtach E, Schmid M, Fuller S, Karanjia S, Love A, Jones R, Rui Y, Thompson D: Structural analysis of membrane bound retrovirus capsid proteins. EMBO J 1996, 16:1199-1213.
34. Barklis E, McDermott J, Wilkens S, Fuller S, Thompson D: Organization of HIV-1 capsid proteins on a lipid monolayer. J Biol Chem 1998, 273:7177-7180. Histidine-tagged capsid proteins were used to generate small crystalline patches of capsid proteins on lipid monolayers. Two-dimensional projections show a cage-like lattice consisting of hexameric and trimeric units surrounding protein-free holes.
35. Nermut MV, Hockley DJ, Bron P, Thomas D, Zhang W-H, Jones IA: Further evidence for hexagonal organization of HIV gag protein in prebudding assemblies and immature virus like particles. J Struct Biol 1998, 123:143-149.
36. Rao Z, Belyaev AS, Fry E, Jones IM, Stuart DI: Crystal structure of the SIV matrix antigen and implications for virus assembly. Nature 1995, 378:743-747.
37. Hill CP, Worthylake D, Bancroft DP, Christensen AM, Sundquist WI: Crystal structures of the trimeric human immunodeficiency virus type 1 matrix protein: Implications for membrane association and assembly. Proc Natl Acad Sci USA 1996, 93:3099-3104.
38. Momany C, Kovari LC, Prongay AJ, Keller W, Gitti RK, Lee BM, Gorbalenya AE, Tong L, McClure J, Shrlich LS et al.: Crystal structure of dimeric HIV-1 capsid protein. Nat Struct Biol 1996, 3:763-770.
39. Gamble TR, Vajdos FF, Yoo S, Worthylake DK, Houseweart M, Sundquist WI: Crystal structure of human cyclophilin A bound to the amino-terminal domain of HIV-1 capsid. Cell 1996, 87:1285-1294.
40. Gamble TR, Yoo S, Vajdos FF, von Schwedler UK, Worthylake DK, Wang H, McCutcheon JP, Sundquist WI, Hill CP: Structure of the carboxyl-terminal dimerization domain of the HIV-1 capsid protein. Science 1997, 278:849-853. This article presents the three-dimensional structure of the C-terminal dimerization domain of the HIV-1 capsid protein. A model for the dimerization of the combined N-terminal and C-terminal domains is presented.
41. Freed EO: HIV-1 Gag protein: Diverse functions in the virus life cycle. Virology 1998, 251:1-15. An excellent and up-to-date review on the role of Gag and Gag-related proteins. The author presents a very detailed and intimate discussion of present knowledge and gives a reliable guide for the interpretation of the numerous functions of Gag.
42. Scarlata S, Ehrlich LS, Carter CA: Membrane-induced alterations in HIV-1 Gag and matrix protein-protein interactions. J Mol Biol 1998, 277:161-169.
43. Borsetti A, Öhagen A, Göttlinger HG: The C-terminal half of the human immunodeficiency virus type I Gag precursor is sufficient for efficient virus assembly. J Virol 1998, 72:9313-9317. This paper shows that the HIV-1 Gag sequence between the myristylation signal and the major homology region are dispensable for efficient particle production.
44. Kräusslich HG: Human immunodeficiency virus proteinase dimer as component of the viral polyprotein prevents particle assembly and viral infectivity. Proc Natl Acad Sci USA 1991, 88:3213-3217.
45. Kräusslich HG, Traenckner AM, Rippmann F: Expression and characterization of genetically linked homo- and hetero-dimers of HIV proteinase. Adv Exp Med Biol 1991, 306:417-428.
46. Wilk T, Gowen BE, Fuller SD: Actin associates with the nucleocapsid domain of the Gag polyprotein in the human immunodeficiency virus (HIV-1). J Virol 1999, 73:1931-1940.
47. Conte MR, Matthews S: Retroviral matrix proteins: A structural perspective. Virology 1998, 246:191-198. This paper presents an overview of the retroviral matrix structures, highlighting common features and differences. The authors compare the influenza matrix protein structure to the retroviral structures and discuss the possible structural basis of some of the functional features of matrix proteins.
48. Kräusslich HG, Welker R: Intracellular transport of retroviral capsid components. Curr Top Microbiol Immunol 1996, 214:25-63.
49. SPearman P, HoRton R, Ratner L, Kuli-Zade I: Membrane binding of human immunodeficiency virus type 1 matrix protein in vivo supports a conformational myristyl switch mechanism. J Virol 1997, 71:6582-6592. This article provides evidence for the modulation of matrix protein membrane binding properties by the myristate. The authors suggest a cleavage-induced conformational change and find no conclusive evidence that the charged surface is essential for Gag membrane binding.
50. Zhou W, Resh MD: Differential membrane binding of the human immunodeficiency virus type 1 matrix protein. J Virol 1996, 70:8540-8548.
51. Rhee SS, HuntEr E: Myristylation is required for intracellular transport but not for assembly of D-type retrovirus capsids. J Virol 1987, 61:1045-1053.
52. Rhee SS, HuntEr E: A single amino acid substitution within the matrix protein of a type D retrovirus converts its morphogenesis to that of a type C retrovirus. Cell 1990, 63:77-86.
53. Simons K, Fuller SD: The budding of enveloped viruses: A paradigm for membrane sorting? in Biological Organization: Macromolecular Interactions at High Resolution. Edited by Burnett RM, Vogel HJ. Orlando, FL: Academic Press; 1987:139-150.
54. Fuller SD, Von Bonsdorff CH, Simons K: Vesicular stomatitis virus infects and matures only through the basolateral surface of the polarized epithelial cell line, MDCK. Cell 1984, 38:65-67.
55. Owens RJ, Compans RW: Expression of the human immunodeficiency virus envelope glycoprotein is restricted to basolateral surfaces of polarized epithelial cells. J Virol 1989, 63:978-982.
56. Owens RJ, Dubay JW, HuntEr E, Compans RW: Human immunodeficiency virus envelope protein determines the site of virus release in polarized epithelial cells. Proc Natl Acad Sci USA 1991, 88:3987-3991.
57. Lodge R, Gottlinger H, GabuzDa D, Cohen EA, Lemay G: The intracytoplasmic domain of gp41 mediates polarized budding of human immunodeficiency virus type 1 in MDCK cells. J Virol 1994, 68:4857-4861.
58. Cosson P: Direct interaction between the envelope and matrix proteins of HIV-1. EMBO J 1996, 15:5783-5788.
59. Dorfman T, Bukovsky A, O'HAgen A, Hoglund S, Gottlinger HG: Functional domains of the capsid protein of human immunodeficiency virus type 1. J Virol 1994, 68:8180-8187.
60. Lee PP, Lineal ML: Efficient particle formation can occur if the matrix domain of human immunodeficiency virus type 1 gag is substituted by a myristylation signal. J Virol 1994, 68:6644-6654.
61. Reil H, Bukovsky AA, Gelderblom HR, Gottlinger HG: Efficient HIV-1 replication can occur in the absence of the viral matrix protein. EMBO J 1998, 17:2699-2708. This paper demonstrates that the matrix protein is dispensable for Gag transport, assembly and particle release. Viral mutants with an additional mutation encoding for a C-terminally truncated gp41 protein replicate efficiently in T cells.
62. Mammano F, OhAgen A, Hoglund S, Gottlinger HG: Role of the major homology region of human immunodeficiency virus type 1 in virion morphogenesis. J Virol 1994, 68:4927-4936.
63. Thali M, Bukovsky A, Kondo E, Rosenwirth B, Walsh CT, Sodroski J, Göttlinger HG: Functional association of cyclophilin A with HIV-1 virions. Nature 1994, 372:363-365.
64. Franke EK, Chen BX, Tatsis I, DiAmAnduros A, Erlanger BF, Luban J: Cyclophilin binding to the human immunodeficiency virus type 1 gag polyprotein is mimicked by an anti-cyclosporin antibody. J Virol 1995, 69:5821-5823.
65. Franke EK, Yuan HE, Luban J: Specific incorporation of cyclophilin A into HIV-1 virions. Nature 1994, 372:359-362.
66. Gross I, HoHenberg H, Kräusslich HG: In vitro assembly properties of purified bacterially expressed capsid proteins of human immunodeficiency virus. Bur J Biochem 1997, 249:592-600.
67. Campbell SJ, Vogt VM: Self-assembly in vitro of purified CA-NC proteins from rous sarcoma virus and human immunodeficiency virus type 1. J Virol 1995, 69:6487-6497.
68. Gitti RK, Lee BM, Walker J, Summers MF, Yoo S, Sundquist WI: Structure of the amino-terminal core domain of the HIV-1 capsid protein. Science 1996, 273:231 -235.
69. Von Schwedler UK, Stemmler TL, Klishko VY, Li S, Albertine KH, Davis DR, Sundquist WI: Proteolytic refolding of the HIV-1 capsid protein amino-terminus facilitates viral core assembly. EMBO J 1998, 17:1555-1568. This paper explores the effects of mutations in the capsid protein both on the in vitro assembly of tubes and spheres from expressed capsid proteins and on virus replication. The authors conclude that the hairpin structure plays an important role in directing assembly towards tubes and the generation of infectious virus.
70. Gross I, HoHenberg H, HuCkhagel C, Kräusslich HG: N-terminal extension of human immunodeficiency virus capsid protein converts the in vitro assembly phenotype from tubular to spherical particles. J Virol 1998, 72:4798-4810. This paper explores the possible role of the uncleaved sequences in the Gag precursor on driving assembly towards the spherical form seen in the immature particle. It provides a direct test of the importance of the N-terminal hairpin in assembly.
71. Aberham C, Weber S, Phares W: Spontaneous mutations in the human immunodeficiency virus type 1 gag gene that affect viral replication in the presence of cyclosporins. J Virol 1996, 70:3536-3544.
72. Braaten D, Aberham C, Franke EK, Yin L, Phares W, Luban J: Cyclosporine A-resistant human immunodeficiency virus type 1 mutants demonstrate that gag encodes the functional target of cyclophilin A. J Virol 1996, 70:5170-5176.
73. Bukovsky AA, WeimAnn A, Accola MA, Gottlinger HG: Transfer of the HIV-1 cyclophilin-binding site to simian immunodeficiency virus from Macaca mulatta can confer both cyclosporin sensitivity and cyclosporin dependence. Proc Natl Acad Sci USA 1997, 94:10943-10948.
74. Jin Z, Jin L, Peterson DL, Lawson CL: Model for lentivirus capsid core assembly based on crystal dimers of EIAV p26. J Mol Biol 1999, 286:83-93. This paper presents the structure of the full-length capsid protein from a lentivirus that is distantly related to HIV. The authors extrapolate from their observation of the hexagonal packing of the antiparallel dimers to the assembly of the lentivirus core.
75. •], demonstrate both the tendency of capsid proteins to form the antiparallel dimer and the flexibility of the linker region.
76. Grättinger M, HoHenberg H, Thomas D, Wilk T, Müller B, Kräusslich HG: In vitro assembly properties of wild-type and cyclophilin-binding defective human immunodeficiency virus capsid proteins in the presence and absence of cyclophilin A. Virology 1999, in press.
77. BeRkowitz R, Fisher J, Goff SP: RNA packaging. Curt Top Microbiol Immunol 1996, 214:177-218.
78. Ott DE, Goren LV, Kane BP, Busch LK, Johnson DG, Sowder RC, Chertova EN, Arthur LO, Henderson LE: Cytoskeletal proteins inside human immunodeficiency virus type I virions. J Virol 1996, 70:7734-7743.
79. Cudmore S, Reckmann I, Way M: Viral manipulations of the actin cytoskeleton. Trends Microbiol 1997, 5:142-148.
80. Summers MF, Henderson LE, Chance MR, Bess JW Jr, South TL, Blake PR, Sagi I, Perez-Alvarado G, Sowder RC, Hare DR et al.: Nucleocapsid zinc fingers detected in retroviruses: EXAFS studies of intact viruses and the solution-state structure of the nucleocapsid protein from HIV-1. Protein Sci 1992, 1:563-574.
81. Morellet N, JulliaN N, De Rocquigny H, Maigret B, Darlix JL, Roques BP: Determination of the structure of the nucleocapsid protein NCp7 from the human immunodeficiency virus type 1 by 1H NMR. EMBO J 1992, 11:3059-3065.
82. De Guzman RN, Wu ZR, Stalling CG, PappaLardo L, Borer PN, Summers MF: Structure of the HIV-1 nucleocapsid protein bound to the SL3 psi-Rna recognition element. Science 1998, 279:384-388. The structure of the nucleocapsid protein bound to an RNA sequence containing the packaging signal is presented. Both specific recognition and nonspecific RNA binding are illustrated.
83. Rice WG, Schaeffer CA, Harten B, Villinger F, South TL, Summers MF, Henderson LE, Bess JW Jr, Arthur LO, McDougal JS et al.: Inhibition of HIV-1 infectivity by zinc-ejecting aromatic C-nitroso compounds. Nature 1993, 361:473-475.
84. Tummino PJ, Scholten JD, Harvey PJ, Holler TP, MaLoney L, Gogliotti R, Domagala J, Hupe D: The in vitro ejection of zinc from human immunodeficiency virus (HIV) type 1 nucleocapsid protein by disulfide benzamides with cellular anti-Hiv activity. Proc Natl Acad Sci USA 1996, 93:969-973.
85. Maurer B, Bannert H, Darai G, Flugel RM: Analysis of the primary structure of the long terminal repeat and the gag and pol genes of the human spumaviruses. J Virol 1988, 62:1590-1597.
86. Dannull J, Surovoy A, JunG G, Moelling K: Specific binding of HIV-1 nucleocapsid protein to PSI RNA in vitro requires N-terminal zinc finger and flanking basic amino acid residues. EMBO J 1994, 13:1525-1533.
87. Berkowitz RD, OhAgen A, Hoglund S, Goff SP: Retroviral nucleocapsid domains mediate the specific recognition of genomic viral RNAs by chimeric gag polyproteins during RNA packaging in vivo. J Virol 1995, 69:6445-6456.
88. Dawson L, Yu XF: The role of nucleocapsid of HIV-1 in virus assembly. Virology 1998, 251:141-157.
89. Poon DT, Wu J, ALdovini A: Charged amino acid residues of human immunodeficiency virus type 1 nucleocapsid p7 protein involved in RNA packaging and infectivity. J Virol 1996, 70:6607-6616.
90. Zhang Y, Qian H, Love Z, Barklis E: Analysis of the assembly function of the human immunodeficiency virus type 1 gag protein nucleocapsid domain. J Virol 1998, 72:1782-1789.
91. Gottlinger HG, Dorfman T, Sodroski JG, Haseltine WA: Effect of mutations affecting the p6 gag protein on human immunodeficiency virus particle release. Proc Natl Acad Sci USA 1991, 88:3195-3199.
92. Huang M, Orenstein JM, MArtin MA, Freed EO: p6Gag is required for particle production from full-length human immunodeficiency virus type 1 molecular clones expressing protease. J Virol 1995, 69:6810-6818.
93. Paxton W, Connor RI, Landau NR: Incorporation of Vpr into human immunodeficiency virus type 1 virions: Requirement for the p6 region of gag and mutational analysis. J Virol 1993, 67:7229-7237.
94. Stys D, Blaha I, StroP P: Structural and functional studies in vitro on the p6 protein from the HIV-1 gag open reading frame. Biochim Biophys Acta 1993, 1182:157-161.
95. Lu YL, Bennett RP, Wills JW, GoRelick R, Ratner L: A leucine triplet repeat sequence (LXX)4 in p6gag is important for Vpr incorporation into human immunodeficiency virus type 1 particles. J Virol 1995, 69:6873-6879.
96. Kondo E, Mammano F, Cohen EA, Gottlinger HG: The p6gag domain of human immunodeficiency virus type 1 is sufficient for the incorporation of Vpr into heterologous viral particles. J Virol 1995, 69:2759-2764.
97. Perutz M: Hemoglobin structure and respiratory transport. Scientific American 1978, 239:92-125.